paraneoplastic syndrome

From Aaushi
Jump to navigation Jump to search

Introduction

Syndrome resulting from distant effects of a neoplasm.

Classification

* most common paraneoplastic syndromes

Etiology

  • cause of paraneoplastic syndromes is generally autoimmune

Clinical manifestations

Laboratory

More general terms

More specific terms

References

  1. Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed) Lippincott-Raven, Philadelphia, 1998, pg 677-678
  2. Harrison's Principles of Internal Medicine, 14th ed. Fauci et al (eds), McGraw-Hill Inc. NY, 1998, pg 619, 621
  3. Jump up to: 3.0 3.1 Medical Knowledge Self Assessment Program (MKSAP) 15, 16, 17. American College of Physicians, Philadelphia 2009, 2012, 2015
  4. Pelosof LC, Gerber DE. Paraneoplastic syndromes: an approach to diagnosis and treatment. Mayo Clin Proc. 2010 Sep;85(9):838-54. PMID: https://www.ncbi.nlm.nih.gov/pubmed/20810794
  5. Titulaer MJ, Soffietti R, Dalmau J et al Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Eur J Neurol. 2011 Jan;18(1):19-e3 PMID: https://www.ncbi.nlm.nih.gov/pubmed/20880069
  6. Vedeler CA, Antoine JC, Giometto B et al Management of paraneoplastic neurological syndromes: report of an EFNS Task Force. Eur J Neurol. 2006 Jul;13(7):682-90. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16834698
  7. Dimitriadis GK, Angelousi A, Weickert MO et al Paraneoplastic endocrine syndromes. Endocr Relat Cancer. 2017 Jun;24(6):R173-R190. PMID: https://www.ncbi.nlm.nih.gov/pubmed/28341725 Review.
  8. NINDS Paraneoplastic Syndromes Information Page https://www.ninds.nih.gov/disorders/all-disorders/paraneoplastic-syndromes-information-page

Patient information

paraneoplastic syndrome patient information